+
データを開く
-
基本情報
| 登録情報 | データベース: PDB / ID: 8aoe | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| タイトル | Specific covalent inhibitor(15) of ERK2 | |||||||||
要素 | Mitogen-activated protein kinase 1 | |||||||||
キーワード | SIGNALING PROTEIN / serine-threonine kinase / transcriptional repressor / cell cycle / ATP binding | |||||||||
| 機能・相同性 | 機能・相同性情報phospho-PLA2 pathway / interleukin-34-mediated signaling pathway / Signaling by MAPK mutants / RAF-independent MAPK1/3 activation / Suppression of apoptosis / Gastrin-CREB signalling pathway via PKC and MAPK / Signaling by Activin / cardiac neural crest cell development involved in heart development / caveolin-mediated endocytosis / cytosine metabolic process ...phospho-PLA2 pathway / interleukin-34-mediated signaling pathway / Signaling by MAPK mutants / RAF-independent MAPK1/3 activation / Suppression of apoptosis / Gastrin-CREB signalling pathway via PKC and MAPK / Signaling by Activin / cardiac neural crest cell development involved in heart development / caveolin-mediated endocytosis / cytosine metabolic process / response to epidermal growth factor / Signaling by NODAL / ERKs are inactivated / Signaling by MAP2K mutants / RSK activation / Golgi Cisternae Pericentriolar Stack Reorganization / Regulation of the apoptosome activity / positive regulation of macrophage proliferation / regulation of cellular pH / outer ear morphogenesis / Signaling by LTK in cancer / regulation of Golgi inheritance / positive regulation of peptidyl-threonine phosphorylation / ERBB signaling pathway / labyrinthine layer blood vessel development / mammary gland epithelial cell proliferation / trachea formation / Negative feedback regulation of MAPK pathway / regulation of early endosome to late endosome transport / IFNG signaling activates MAPKs / regulation of stress-activated MAPK cascade / Frs2-mediated activation / positive regulation of macrophage chemotaxis / ERBB2-ERBB3 signaling pathway / Activation of the AP-1 family of transcription factors / regulation of cytoskeleton organization / ERK/MAPK targets / RUNX2 regulates osteoblast differentiation / response to exogenous dsRNA / MAPK1 (ERK2) activation / pseudopodium / lung morphogenesis / face development / positive regulation of telomere maintenance / Bergmann glial cell differentiation / Recycling pathway of L1 / thyroid gland development / Advanced glycosylation endproduct receptor signaling / peptidyl-threonine phosphorylation / regulation of ossification / MAP kinase activity / negative regulation of cell differentiation / RHO GTPases Activate NADPH Oxidases / Regulation of HSF1-mediated heat shock response / Estrogen-dependent nuclear events downstream of ESR-membrane signaling / mitogen-activated protein kinase / RHO GTPases Activate WASPs and WAVEs / Signal attenuation / phosphatase binding / Growth hormone receptor signaling / Estrogen-stimulated signaling through PRKCZ / Schwann cell development / stress-activated MAPK cascade / Nuclear events stimulated by ALK signaling in cancer / NPAS4 regulates expression of target genes / ERK1 and ERK2 cascade / phosphotyrosine residue binding / myelination / Transcriptional and post-translational regulation of MITF-M expression and activity / NCAM signaling for neurite out-growth / RNA polymerase II CTD heptapeptide repeat kinase activity / insulin-like growth factor receptor signaling pathway / cellular response to amino acid starvation / ESR-mediated signaling / lipopolysaccharide-mediated signaling pathway / thymus development / Regulation of PTEN gene transcription / Signal transduction by L1 / B cell receptor signaling pathway / response to nicotine / FCGR3A-mediated phagocytosis / FCERI mediated MAPK activation / Negative regulation of FGFR3 signaling / Negative regulation of FGFR2 signaling / Negative regulation of FGFR4 signaling / Downregulation of SMAD2/3:SMAD4 transcriptional activity / Negative regulation of FGFR1 signaling / SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription / positive regulation of cholesterol biosynthetic process / Spry regulation of FGF signaling / Signaling by high-kinase activity BRAF mutants / MAP2K and MAPK activation / Oncogene Induced Senescence / caveola / regulation of protein stability / Regulation of actin dynamics for phagocytic cup formation / epidermal growth factor receptor signaling pathway / long-term synaptic potentiation / chemotaxis / Interferon gamma signaling 類似検索 - 分子機能 | |||||||||
| 生物種 | Homo sapiens (ヒト) | |||||||||
| 手法 | X線回折 / フーリエ合成 / 解像度: 1.687 Å | |||||||||
データ登録者 | Cleasby, A. | |||||||||
| 資金援助 | 英国, 1件
| |||||||||
引用 | ジャーナル: J.Med.Chem. / 年: 2022タイトル: X-ray Screening of an Electrophilic Fragment Library and Application toward the Development of a Novel ERK 1/2 Covalent Inhibitor. 著者: St Denis, J.D. / Chessari, G. / Cleasby, A. / Cons, B.D. / Cowan, S. / Dalton, S.E. / East, C. / Murray, C.W. / O'Reilly, M. / Peakman, T. / Rapti, M. / Stow, J.L. | |||||||||
| 履歴 |
|
-
構造の表示
| 構造ビューア | 分子: Molmil Jmol/JSmol |
|---|
-
ダウンロードとリンク
-
ダウンロード
| PDBx/mmCIF形式 | 8aoe.cif.gz | 164.1 KB | 表示 | PDBx/mmCIF形式 |
|---|---|---|---|---|
| PDB形式 | pdb8aoe.ent.gz | 125.7 KB | 表示 | PDB形式 |
| PDBx/mmJSON形式 | 8aoe.json.gz | ツリー表示 | PDBx/mmJSON形式 | |
| その他 | その他のダウンロード |
-検証レポート
| 文書・要旨 | 8aoe_validation.pdf.gz | 801.6 KB | 表示 | wwPDB検証レポート |
|---|---|---|---|---|
| 文書・詳細版 | 8aoe_full_validation.pdf.gz | 803.1 KB | 表示 | |
| XML形式データ | 8aoe_validation.xml.gz | 18.8 KB | 表示 | |
| CIF形式データ | 8aoe_validation.cif.gz | 29.4 KB | 表示 | |
| アーカイブディレクトリ | https://data.pdbj.org/pub/pdb/validation_reports/ao/8aoe ftp://data.pdbj.org/pub/pdb/validation_reports/ao/8aoe | HTTPS FTP |
-関連構造データ
| 関連構造データ | ![]() 8ao2C ![]() 8ao3C ![]() 8ao4C ![]() 8ao5C ![]() 8ao6C ![]() 8ao7C ![]() 8ao8C ![]() 8ao9C ![]() 8aoaC ![]() 8aobC ![]() 8aocC ![]() 8aodC ![]() 8aofC ![]() 8aogC ![]() 8aohC ![]() 8aoiC ![]() 8aojC C: 同じ文献を引用 ( |
|---|---|
| 類似構造データ | 類似検索 - 機能・相同性 F&H 検索 |
-
リンク
-
集合体
| 登録構造単位 | ![]()
| ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 1 |
| ||||||||
| 単位格子 |
|
-
要素
| #1: タンパク質 | 分子量: 42551.922 Da / 分子数: 1 / 由来タイプ: 組換発現 / 由来: (組換発現) Homo sapiens (ヒト) / 遺伝子: MAPK1, ERK2, PRKM1, PRKM2 / 発現宿主: ![]() | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| #2: 化合物 | ChemComp-SO4 / | ||||||||
| #3: 化合物 | | #4: 化合物 | ChemComp-N6U / ~{ | #5: 水 | ChemComp-HOH / | 研究の焦点であるリガンドがあるか | Y | Has protein modification | Y | |
-実験情報
-実験
| 実験 | 手法: X線回折 / 使用した結晶の数: 1 |
|---|
-
試料調製
| 結晶 | マシュー密度: 2.31 Å3/Da / 溶媒含有率: 46.68 % |
|---|---|
| 結晶化 | 温度: 293 K / 手法: 蒸気拡散法, ハンギングドロップ法 / pH: 7.2 詳細: 0.25M (NH4)2SO4 33% MPEG 2000 0.02M Mercaptoethanol 0.1M pH=7.2 HEPES/NaOH |
-データ収集
| 回折 | 平均測定温度: 100 K / Serial crystal experiment: N |
|---|---|
| 放射光源 | 由来: 回転陽極 / タイプ: RIGAKU FR-E SUPERBRIGHT / 波長: 1.54178 Å |
| 検出器 | タイプ: DECTRIS PILATUS 300K / 検出器: PIXEL / 日付: 2019年12月20日 |
| 放射 | プロトコル: SINGLE WAVELENGTH / 単色(M)・ラウエ(L): M / 散乱光タイプ: x-ray |
| 放射波長 | 波長: 1.54178 Å / 相対比: 1 |
| 反射 | 解像度: 1.687→56.88 Å / Num. obs: 43578 / % possible obs: 91.9 % / 冗長度: 3.1 % / Rrim(I) all: 0.083 / Net I/σ(I): 12.2 |
| 反射 シェル | 解像度: 1.687→1.752 Å / Num. unique obs: 263 / Rrim(I) all: 1.084 |
-
解析
| ソフトウェア |
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 精密化 | 構造決定の手法: フーリエ合成 / 解像度: 1.687→43.48 Å / Cor.coef. Fo:Fc: 0.95 / Cor.coef. Fo:Fc free: 0.932 / SU R Cruickshank DPI: 0.167 / 交差検証法: THROUGHOUT / σ(F): 0 / SU R Blow DPI: 0.133 / SU Rfree Blow DPI: 0.127 / SU Rfree Cruickshank DPI: 0.121 詳細: HYDROGENS WERE FULLY REFINED U VALUES : WITH TLS ADDED WITH FULL OCCUPANCY AT NUCLEAR POSITION. REFINEMENT NOTES. NUMBER OF REFINEMENT NOTES : 1 NOTE 1 : IDEAL-DIST CONTACT TERM CONTACT SETUP. ...詳細: HYDROGENS WERE FULLY REFINED U VALUES : WITH TLS ADDED WITH FULL OCCUPANCY AT NUCLEAR POSITION. REFINEMENT NOTES. NUMBER OF REFINEMENT NOTES : 1 NOTE 1 : IDEAL-DIST CONTACT TERM CONTACT SETUP. ALL ATOMS HAVE CCP4 ATOM TYPE FROM LIBRARY
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 原子変位パラメータ | Biso max: 97.9 Å2 / Biso mean: 30.238 Å2 / Biso min: 7.47 Å2
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Refine analyze | Luzzati coordinate error obs: 0.23 Å | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 精密化ステップ | サイクル: final / 解像度: 1.687→43.48 Å
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 拘束条件 |
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| LS精密化 シェル | 解像度: 1.69→1.75 Å / Rfactor Rfree error: 0 / Total num. of bins used: 51
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 精密化 TLS | 手法: refined / Origin x: -1.2989 Å / Origin y: 3.276 Å / Origin z: 37.7648 Å
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 精密化 TLSグループ | Selection details: { A|11 - A|356 } |
ムービー
コントローラー
万見について




Homo sapiens (ヒト)
X線回折
英国, 1件
引用
















PDBj




































